Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2014
10/23/2014US20140315868 Organic compounds
10/23/2014US20140314674 Treatment of cancer with dihydropyrazino-pyrazines
10/23/2014US20140314673 Treatment of cancer with dihydropyrazino-pyrazines
10/21/2014US8865895 Organic compound, anisotropic optical film and method of production thereof
10/21/2014US8865891 Optically-detectable enzyme substrates and their method of use
10/21/2014US8865890 Redox-active structures and devices utilizing the same
10/21/2014US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865729 Salt forms of a xanthine compound
10/21/2014US8865726 Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
10/21/2014US8865725 Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865719 Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors
10/21/2014US8865715 Substituted 7-(1,2,3-Triazol-4-yl)-pyrrolo[2,3-b]pyrazines
10/21/2014US8865713 Benzoimidazoles as prolyl hydroxylase inhibitors
10/21/2014US8865712 Heterocyclic derivatives and their use in the treatment of neurological disorders
10/21/2014US8865711 Phenylimidazole derivatives as PDE10A enzyme inhibitors
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865702 B1-antagonists
10/21/2014US8865698 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/16/2014US20140309420 One pot process for preparing pemetrexed disodium
10/16/2014US20140309241 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof
10/16/2014US20140309223 Tyrosine kinase inhibitors
10/16/2014US20140309213 Inhibitors of the renal outer medullary potassium channel
10/16/2014US20140309212 Bruton's tyrosine kinase inhibitors
10/16/2014US20140309207 Novel spiroindoline compound, and medicinal agent comprising same
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/16/2014US20140309135 Remedy for diabetes
10/14/2014US8859822 Synthesis of substituted salicylaldehyde derivatives
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859784 Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors
10/14/2014US8859775 Pyrazolopyridinone derivatives as LPA receptor antagonists
10/14/2014US8859769 Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
10/14/2014US8859764 Methods and compositions for preparing noribogaine from voacangine
10/14/2014US8859609 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859583 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859572 Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis
10/14/2014US8859569 Substituted annellated pyrimidines and use thereof
10/14/2014US8859568 Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy
10/14/2014US8859565 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof
10/14/2014US8859564 Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/14/2014US8859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer
10/14/2014US8859550 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/14/2014US8859543 Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
10/14/2014US8859538 Uses of substituted imidazoheterocycles
10/14/2014US8859512 Anti-viral pyrimidine nucleoside derivatives
10/14/2014US8859191 Pattern-forming method, and composition for forming resist underlayer film
10/09/2014WO2014165119A1 Cyclodextrin and antibody-drug conjugate formulations
10/09/2014WO2014165070A1 Substituted 2-azabicycles and their use as orexin receptor modulators
10/09/2014WO2014164771A1 Bromodomain inhibitors
10/09/2014WO2014164729A1 Substituted tricyclic pyrazolo-pyrimidine compounds
10/09/2014WO2014164596A1 Bet bromodomain inhibitors and therapeutic methods using the same
10/09/2014WO2014164467A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014164428A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014161888A1 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
10/09/2014WO2014161801A1 Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
10/09/2014US20140303366 Certain 1H-Imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-Imidazo[4,5-b]pyrazin-2-ols and Methods for Their Use
10/09/2014US20140303196 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
10/09/2014US20140303190 Tyrosine kinase inhibitors
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303178 Dihydropyrazolopyrimidinone derivatives
10/09/2014US20140303177 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303161 Tyrosine kinase inhibitors
10/09/2014US20140303159 Macrocyclic flt3 kinase inhibitors
10/09/2014US20140303158 Fused heterocyclic compounds as ion channel modulators
10/09/2014US20140303149 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
10/09/2014US20140303144 Compounds and methods of treating hypertension
10/09/2014US20140302539 Coelenterazine analogs
10/09/2014US20140302066 Pyrrolobenzodiazepines and targeted conjugates
10/09/2014US20140301937 Fullerene separation through use of organic cages
10/08/2014EP2785720A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/08/2014EP2785717A1 Pyrazolopyrrolidine compounds
10/08/2014EP2785716A1 Novel crystalline form of ticagrelor and process for the preparation thereof
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785325A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
10/07/2014US8853420 Compounds
10/07/2014US8853398 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
10/07/2014US8853395 Process for the preparation of lurasidone hydrochloride
10/07/2014US8853394 Pharmacokinetically improved compounds
10/07/2014US8853224 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
10/07/2014US8853220 Synthesis of 2,6,9-tri-substituted-4,8-dinitro-2,6,9-triazabicyclo[3.3.1]nona-3,7-diene intermediates toward the preparation of polyaza-adamantanes
10/07/2014US8853213 Bicyclic compound for modulating G protein-coupled receptors
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853206 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
10/07/2014US8853201 Sulfate esters of noribogaine
10/07/2014US8853171 1′-substituted carba-nucleoside analogs for antiviral treatment
10/07/2014US8853125 Pyrazole compounds for controlling invertebrate pests
10/07/2014US8852953 Immunodetection and quantification of pyrazolopyrimidine sedatives
10/07/2014US8852756 Materials for organic electroluminescent devices
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160258A1 Oxygen sensors
10/02/2014WO2014160203A2 Bmp inhibitors and methods of use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 573